Showing results (31-40 of 50) with videos related to
Sort By:
Pageof 5
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 1, 1997
Interphase cytogenetic analysis of mucinous ovarian neoplasmsJ Diebold, S Siegert, G B Baretton, et al.Virchows Archiv : an International Journal of Pathology|November 1, 1996
DNA ploidy and MYC DNA amplification in ovarian carcinomas. Correlation with p53 and bcl-2 expression, proliferative activity and prognosisJ Diebold, B Suchy, G B Baretton, et al.Proceedings of the National Academy of Sciences of the United States of America|June 9, 1999
p53 gene mutations are not required for early dissemination of cancer cellsS Offner, W Schmaus, K Witter, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|September 27, 2000
FISH analysis of gene aberrations (MYC, CCND1, ERBB2, RB, and AR) in advanced prostatic carcinomas before and after androgen deprivation therapyC Kaltz-Wittmer, U Klenk, A Glaessgen, et al.The Prostate|May 27, 1999
Microsatellite instability and loss of heterozygosity in prostatic carcinomas: comparison of primary tumors, and of corresponding recurrences after androgen-deprivation therapy and lymph-node metastasesH Rohrbach, C J Haas, G B Baretton, et al.The Journal of Pathology|March 23, 2000
20q13 and cyclin D1 in ovarian carcinomas. Analysis by fluorescence in situ hybridizationJ Diebold, K Mösinger, G Peiro, et al.Pathology, Research and Practice|August 5, 2000
Immunohistochemical analysis of drug resistance-associated proteins in ovarian carcinomasD Mayr, U Pannekamp, G B Baretton, et al.International Journal of Radiation Biology|December 31, 2003
Sustained elevation of NF-kappaB DNA binding activity in radiation-induced lung damage in ratsM G Haase, A Klawitter, P Geyer, et al.Cancer|January 15, 1996
Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significanceG B Baretton, J Diebold, G Christoforis, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|October 1, 1996
Interphase cytogenetic analysis of serous ovarian tumors of low malignant potential: comparison with serous cystadenomas and invasive serous carcinomasJ Diebold, I Deisenhofer, G B Baretton, et al.Pageof 5